Sorry, you need to enable JavaScript to visit this website.
Skip to main content


Doxazosin Mesilate

Therapeutic Category
Anti-hypertensive/ Benign Prostatic Hyperplasia - BPH
API Technology
Synthetic
Dose From
Oral Solids
Dr Reddy's Development Status
Available
Available Regulatory Filing
USA
Canada
CEP
Korea
Taiwan
Brazil
Innovator Brand (USA)
CARDURA

We are here to help, if you have any country specific requirements - please Contact Us.